scholarly journals Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial

10.2196/16413 ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. e16413
Author(s):  
Laura Fiona Gruner ◽  
Michael Hoffmeister ◽  
Leopold Ludwig ◽  
Hermann Brenner

Background Fecal occult blood testing has been offered for many years in the German health care system, but participation rates have been notoriously low. Objective The aim of this study is to evaluate the effect of various personal invitation schemes on the use of fecal immunochemical tests (FITs) in persons aged 50-54 years. Methods This study consists of a three-armed randomized controlled trial: (1) arm A: an invitation letter from a health insurance plan including a FIT test kit, (2) arm B: an invitation letter from a health insurance plan including an offer to receive a free FIT test kit by mail upon easy-to-handle request (ie, by internet, fax, or reply mail), and (3) arm C: an information letter on an existing colonoscopy offer (ie, control). Within arms A and B, a random selection of 50% of the study population will receive reminder letters, the effects of which are to be evaluated in a substudy. Results A total of 17,532 persons aged 50-54 years in a statutory health insurance plan in the southwest of Germany—AOK Baden-Wuerttemberg—were sent an initial invitation, and 5825 reminder letters were sent out. The primary end point is FIT usage within 1 year from receipt of invitation or information letter. The main secondary end points include gender-specific FIT usage within 1 year, rates of positive test results, rates of colonoscopies following a positive test result, and detection rates of advanced neoplasms. The study was launched in September 2017. Data collection and workup were completed in fall 2019. Conclusions This randomized controlled trial will provide important empirical evidence for enhancing colorectal cancer screening offers in the German health care system. Trial Registration German Clinical Trials Register (DRKS) DRKS00011858; https://bit.ly/2UBTIdt International Registered Report Identifier (IRRID) DERR1-10.2196/16413

2019 ◽  
Author(s):  
Laura Fiona Gruner ◽  
Michael Hoffmeister ◽  
Leopold Ludwig ◽  
Hermann Brenner

BACKGROUND Fecal occult blood testing has been offered for many years in the German health care system, but participation rates have been notoriously low. OBJECTIVE The aim of this study is to evaluate the effect of various personal invitation schemes on the use of fecal immunochemical tests (FITs) in persons aged 50-54 years. METHODS This study consists of a three-armed randomized controlled trial: (1) arm A: an invitation letter from a health insurance plan including a FIT test kit, (2) arm B: an invitation letter from a health insurance plan including an offer to receive a free FIT test kit by mail upon easy-to-handle request (ie, by internet, fax, or reply mail), and (3) arm C: an information letter on an existing colonoscopy offer (ie, control). Within arms A and B, a random selection of 50% of the study population will receive reminder letters, the effects of which are to be evaluated in a substudy. RESULTS A total of 17,532 persons aged 50-54 years in a statutory health insurance plan in the southwest of Germany—AOK Baden-Wuerttemberg—were sent an initial invitation, and 5825 reminder letters were sent out. The primary end point is FIT usage within 1 year from receipt of invitation or information letter. The main secondary end points include gender-specific FIT usage within 1 year, rates of positive test results, rates of colonoscopies following a positive test result, and detection rates of advanced neoplasms. The study was launched in September 2017. Data collection and workup were completed in fall 2019. CONCLUSIONS This randomized controlled trial will provide important empirical evidence for enhancing colorectal cancer screening offers in the German health care system. CLINICALTRIAL German Clinical Trials Register (DRKS) DRKS00011858; https://bit.ly/2UBTIdt INTERNATIONAL REGISTERED REPORT DERR1-10.2196/16413


2021 ◽  
Author(s):  
Anup Malani ◽  
Phoebe Holtzman ◽  
Kosuke Imai ◽  
Cynthia Kinnan ◽  
Morgen Miller ◽  
...  

2000 ◽  
Vol 31 (4) ◽  
pp. 315-322 ◽  
Author(s):  
Joni A. Mayer ◽  
Elizabeth C. Lewis ◽  
Donald J. Slymen ◽  
Joanna Dullum ◽  
Heather Kurata ◽  
...  

2017 ◽  
Vol 24 (6) ◽  
pp. 1095-1101 ◽  
Author(s):  
Kenneth S Boockvar ◽  
William Ho ◽  
Jennifer Pruskowski ◽  
Katherine E DiPalo ◽  
Jane J Wong ◽  
...  

Abstract Objectives To determine the effect of health information exchange (HIE) on medication prescribing for hospital inpatients in a cluster-randomized controlled trial, and to examine the prescribing effect of availability of information from a large pharmacy insurance plan in a natural experiment. Methods Patients admitted to an urban hospital received structured medication reconciliation by an intervention pharmacist with (intervention) or without (control) access to a regional HIE. The HIE contained prescribing information from the largest hospitals and pharmacy insurance plan in the region for the first 10 months of the study, but only from the hospitals for the last 21 months, when data charges were imposed by the insurance plan. The primary endpoint was discrepancies between preadmission and inpatient medication regimens, and secondary endpoints included adverse drug events (ADEs) and proportions of rectified discrepancies. Results Overall, 186 and 195 patients were assigned to intervention and control, respectively. Patients were 60 years old on average and took a mean of 7 medications before admission. There was no difference between intervention and control in number of risk-weighted discrepancies (6.4 vs 5.8, P = .452), discrepancy-associated ADEs (0.102 vs 0.092 per admission, P = .964), or rectification of discrepancies (0.026 vs 0.036 per opportunity, P = .539). However, patients who received medication reconciliation with pharmacy insurance data available had more risk-weighted medication discrepancies identified than those who received usual care (8.0 vs 5.9, P = .038). Discussion and Conclusion HIE may improve outcomes of medication reconciliation. Charging for access to medication information interrupts this effect. Efforts are needed to understand and increase prescribers’ rectification of medication discrepancies.


2021 ◽  
Author(s):  
Anup Malani ◽  
Phoebe Holtzman ◽  
Kosuke Imai ◽  
Cynthia Kinnan ◽  
Morgen Miller ◽  
...  

2021 ◽  
Author(s):  
Anup Malani ◽  
Phoebe Holtzman ◽  
Kosuke Imai ◽  
Cynthia Kinnan ◽  
Morgen Miller ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document